Futibatinib
About
Therapy type: Targeted therapy
Therapy strategy: FGFR inhibition
Mappings
NCI Thesaurus: Futibatinib (ncit:C114283)
RxNorm: futibatinib (rxcui:2628190, omop:1301597)
SNOMED: Futibatinib (sctid:1351548001, omop:1449216)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Futibatinib | |
| EMA (1) | FGFR2 rearrangements | Cholangiocarcinoma | Futibatinib | |
| EMA (1) | FGFR2::v | Cholangiocarcinoma | Futibatinib |